Clinical Trials Browser

Urinary Bladder Neoplasms × enfortumab vedotin × 30 days × Clear all

NCT04963153 2026-03-18

Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy

Phase 1 Active not recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT07232602 2026-03-16

MK-3475-04D

Phase 1/2 Recruiting

Urinary Bladder Neoplasms

NCT07421700 2026-02-19

A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Phase 1/2 Not yet recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell